Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/199586
Title: Orthogonal high-density mapping with ventricular tachycardia isthmus analysis vs. pure substrate ventricular tachycardia ablation: A case–control study
Author: Vázquez Calvo, Sara
Garre Anguera de Sojo, Paz
Sánchez Somonte, Paula
Borràs, Roger
Quinto, Levio
Caixal, Gala
Pujol López, Margarida
Althoff, Till
Guasch, Eduard
Arbelo, Elena
Tolosana, José M. (José María)
Brugada Terradellas, Josep, 1958-
Mont Girbau, Lluís
Roca Luque, Ivo
Keywords: Catèters
Malalties del cor
Estudi de casos
Catheters
Case studies
Heart diseases
Issue Date: 1-Aug-2022
Publisher: Frontiers
Abstract: Substrate-based ablation has become a successful technique for ventricular tachycardia (VT) ablation. High-density (HD) mapping catheters provide high-resolution electroanatomical maps and better discrimination of local abnormal electrograms. The HD Grid Mapping Catheter is an HD catheter with the ability to map orthogonal signals on top of conventional bipolar signals, which could provide better discrimination of the arrhythmic substrate. On the other hand, conventional mapping techniques, such as activation mapping, when possible, help to identify the isthmus of the tachycardia.The purpose of this study was to compare clinical outcomes after using two different VT ablation strategies: one based on extensive mapping with the HD Grid Mapping Catheter, including VT isthmus analysis, and the other based on pure substrate ablation.Forty consecutive patients undergoing VT ablation with extensive HD mapping method in the hospital clinic (November 2018-November 2019) were included. Clinical outcomes were compared with a historical cohort of 26 consecutive patients who underwent ablation using a scar dechanneling technique before 2018.The density of mapping points was higher in the extensive mapping group (2370.24 ± 920.78 vs. 576.45 ± 294.46; p < 0.001). After 1 year of follow-up, VT recurred in 18.4% of patients in the extensive mapping group vs. 34.6% of patients in the historical control group (p = 0.14), with a significantly greater reduction of VT burden: VT episodes (81.7 ± 7.79 vs. 43.4 ± 19.9%, p < 0.05), antitachycardia pacing (99.45 ± 2.29 vs. 33.9 ± 102.5%, p < 0.001), and implantable cardioverter defibrillator (ICD) shocks (99 ± 4.5 vs. 64.7 ± 59.9%, p = 0.02).The use of a method based on extensive mapping with the HD Grid Mapping Catheter and VT isthmus analysis allows better discrimination of the arrhythmic substrate and could be associated with a greater decrease in VT burden.Copyright © 2022 Vázquez-Calvo, Garre, Sanchez-Somonte, Borras, Quinto, Caixal, Pujol-Lopez, Althoff, Guasch, Arbelo, Tolosana, Brugada, Mont and Roca-Luque.
Note: Reproducció del document publicat a: https://doi.org/10.3389/fcvm.2022.912335
It is part of: Frontiers in Cardiovascular Medicine, 2022, vol. 9
URI: http://hdl.handle.net/2445/199586
Related resource: https://doi.org/10.3389/fcvm.2022.912335
ISSN: 2297-055X
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)



This item is licensed under a Creative Commons License Creative Commons